LINC01614 and lung adenocarcinoma: Furthermore, we found that LINC01614 was significantly upregulated in both lung adenocarcinoma tissues and lung squamous cell carcinoma tissues, with an average increased fold of 3.72 (Table S6) and 2.95 (Table S7) respectively.